Latest Tri Locum Partners LP Stock Portfolio
$395Million– No. of Holdings #25
Tri Locum Partners LP Performance:
2024 Q2: 8.18%YTD: 25.66%2023: 17.97%
Performance for 2024 Q2 is 8.18%, and YTD is 25.66%, and 2023 is 17.97%.
About Tri Locum Partners LP and 13F Hedge Fund Stock Holdings
In it's latest 13F Holdings report, Tri Locum Partners LP reported an equity portfolio of $395.5 Millions as of 30 Jun, 2024.
The top stock holdings of Tri Locum Partners LP are TEVA, , . The fund has invested 10.5% of it's portfolio in TEVA PHARMACEUTICAL INDS LTD and 8.1% of portfolio in ARGENX SE.
The fund managers got completely rid off SILK RD MED INC (SILK), MERCK & CO INC (MRK) and VERTEX PHARMACEUTICALS INC (VRTX) stocks. They significantly reduced their stock positions in XENON PHARMACEUTICALS INC (XENE) and PRAXIS PRECISION MEDICINES I (PRAX). Tri Locum Partners LP opened new stock positions in AMGEN INC (AMGN), INSMED INC (INSM) and PFIZER INC (PFE). The fund showed a lot of confidence in some stocks as they added substantially to INSPIRE MED SYS INC (INSP), AXSOME THERAPEUTICS INC (AXSM) and ARGENX SE.
The top stock holdings of Tri Locum Partners LP are TEVA, , . The fund has invested 10.5% of it's portfolio in TEVA PHARMACEUTICAL INDS LTD and 8.1% of portfolio in ARGENX SE.
The fund managers got completely rid off SILK RD MED INC (SILK), MERCK & CO INC (MRK) and VERTEX PHARMACEUTICALS INC (VRTX) stocks. They significantly reduced their stock positions in XENON PHARMACEUTICALS INC (XENE) and PRAXIS PRECISION MEDICINES I (PRAX). Tri Locum Partners LP opened new stock positions in AMGEN INC (AMGN), INSMED INC (INSM) and PFIZER INC (PFE). The fund showed a lot of confidence in some stocks as they added substantially to INSPIRE MED SYS INC (INSP), AXSOME THERAPEUTICS INC (AXSM) and ARGENX SE.
Tri Locum Partners LP Equity Portfolio Value
Last Reported on: 14 Aug, 2024
Tri Locum Partners LP Annual Return Estimates Vs S&P 500
Our best estimate is that Tri Locum Partners LP made a return of 8.18% in the last quarter. In trailing 12 months, it's portfolio return was 44.72%.
New Buys
| Ticker | $ Bought |
|---|---|
| amgen inc | 25,705,600 |
| insmed inc | 21,205,600 |
| pfizer inc | 16,701,800 |
| united therapeutics corp del | 15,959,400 |
| alnylam pharmaceuticals inc | 10,935,000 |
| stevanato group s p a | 10,369,800 |
| novo-nordisk a s | 9,108,380 |
| vaxcyte inc | 8,558,600 |
New stocks bought by Tri Locum Partners LP
Additions
| Ticker | % Inc. |
|---|---|
| inspire med sys inc | 465 |
| axsome therapeutics inc | 198 |
| argenx se | 166 |
| regeneron pharmaceuticals | 104 |
| ascendis pharma a/s | 102 |
| legend biotech corp | 25.64 |
| madrigal pharmaceuticals inc | 22.49 |
| natera inc | 21.29 |
Additions to existing portfolio by Tri Locum Partners LP
Reductions
| Ticker | % Reduced |
|---|---|
| xenon pharmaceuticals inc | -50.85 |
| praxis precision medicines i | -29.27 |
Tri Locum Partners LP reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| silk rd med inc | -19,851,600 |
| lyra therapeutics inc | -6,088,090 |
| perspective therapeutics inc | -928,561 |
| arcutis biotherapeutics inc | -4,456,470 |
| astria therapeutics inc | -5,201,400 |
| tandem diabetes care inc | -11,561,600 |
| baxter intl inc | -13,572,800 |
| arcturus therapeutics hldgs | -4,691,560 |
Tri Locum Partners LP got rid off the above stocks
Sector Distribution
Tri Locum Partners LP has about 74.5% of it's holdings in Healthcare sector.
| Sector | % |
|---|---|
| Healthcare | 74.5 |
| Others | 25.5 |
Market Cap. Distribution
Tri Locum Partners LP has about 44.3% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| LARGE-CAP | 44.3 |
| UNALLOCATED | 25.5 |
| MID-CAP | 23.6 |
| SMALL-CAP | 6.6 |
Stocks belong to which Index?
About 34.7% of the stocks held by Tri Locum Partners LP either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| Others | 65.3 |
| RUSSELL 2000 | 19.3 |
| S&P 500 | 15.4 |
Tri Locum Partners LP Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of Tri Locum Partners LP
Tri Locum Partners LP has 25 stocks in it's portfolio. About 65.2% of the portfolio is in top 10 stocks. INSP proved to be the most loss making stock for the portfolio. INSM was the most profitable stock for Tri Locum Partners LP last quarter.
Last Reported on: 14 Aug, 2024| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| ALNY | alnylam pharmaceuticals inc | 2.77 | 45,000 | 10,935,000 | new | |||
| ALPN | alpine immune sciences inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| AMGN | amgen inc | 6.50 | 82,271 | 25,705,600 | new | |||
| ARCT | arcturus therapeutics hldgs | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| ARQT | arcutis biotherapeutics inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| ATXS | astria therapeutics inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| AVDL | avadel pharmaceuticals plc | 4.23 | 1,189,520 | 16,724,600 | added | 0.00 | ||
| AXSM | axsome therapeutics inc | 6.24 | 306,513 | 24,674,300 | added | 198 | ||
| BAX | baxter intl inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| EXAS | exact sciences corp | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| FEMY | femasys inc | 0.01 | 30,606 | 34,891 | unchanged | 0.00 | ||
| INSM | insmed inc | 5.36 | 316,501 | 21,205,600 | new | |||
| INSP | inspire med sys inc | 4.51 | 133,276 | 17,836,300 | added | 465 | ||
| LYRA | lyra therapeutics inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| MDGL | madrigal pharmaceuticals inc | 4.63 | 65,352 | 18,309,000 | added | 22.49 | ||
| MNMD | mind medicine mindmed inc | 0.70 | 382,055 | 2,754,620 | added | 0.65 | ||
| MRK | merck & co inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| MRUS | merus n v | 5.02 | 335,514 | 19,852,400 | added | 17.18 | ||
| NTRA | natera inc | 6.31 | 230,585 | 24,970,000 | added | 21.29 | ||
| OCUL | ocular therapeutix inc | 0.89 | 514,642 | 3,520,150 | new | |||